A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia
- 1 June 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (6) , 750-755
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Acute myeloid leukemia in elderly adultsHematological Oncology, 1990
- Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemiaEuropean Journal of Cancer and Clinical Oncology, 1987
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB studyBlood, 1982
- Treatment of acute myelocytic leukemia: a study by cancer and leukemia group BBlood, 1981
- Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemiaBlood, 1981
- Reporting results of cancer treatmentCancer, 1981
- Failure of remission induction in acute myelocytic leukemiaMedical and Pediatric Oncology, 1978
- Aging and Immune Function1978